From: COVID-19 testing protocols to guide duration of isolation: a cost-effectiveness analysis
Parameter | Base-case input | Uncertainty range | Source |
---|---|---|---|
Health parameters | |||
% still infectious on day 5 | 90% | 45 – 100% | Wolfel 2020 [16] |
Reduction in portion with infectious virus from day 5 to 6 | 22% | 0 – 50% | Wolfel 2020 [16] |
Secondary reproduction number | 1.2 | 0.96–1.4 | CMMID 2022 [20] |
Intervention parameters | |||
Symptom check sensitivity | 23.8% | 18.4 – 33.3% | |
Antigen test sensitivity | 79.3% | 65.3 – 93.3% | Pilarowski 2021 [23]; see text |
PCR test sensitivity | 89.0% | 83.0 – 93.0% | |
Intervention reach or adherence (same for all interventions) | 100% | 0 – 100% | Assumed |
Effectiveness of isolation for reducing transmission | 95% | Â | Assumed |
Cost parameters (per person) | |||
Antigen test cost | $10 | $5 – $15 | |
PCR test cost | $150 | $100 – $200 | |
Direct medical cost per secondary infection | $1436 | $500 – $2000 | Rae 2020 [29] |
Daily productivity | $200 | Â | Assumed; $25 per hour |
Productivity drop in isolation | 90% | Â | Assumed |